Treatment of Heavy menses by Ayurvedic.

A COMPARATIVE CLINICAL EVALUATION OF SHATAVARI TAIL MATRA BASTI AND NASYA ON ASRUGDAR w.s.r TO DUB. - Basya

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/07/035235

Enrollment

Registered

2021-07-29

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E280- Estrogen excess

Interventions

Intervention1: Shatavari Tail: Minimum 60 Patients Of Asrugdar(DUB) are to be taken and divided into two groups of 30-30 Patients.One Group is to be treated with Shatavari Tail Matra Basti for 7days i

Eligibility

Inclusion criteria

Inclusion criteria: BOTH MARRIED AND UNMARRIED PATIENT. PATIENT DIAGNOSED AS DUB WITHOUT ANY OTHER PATHOLOGY

Exclusion criteria

Exclusion criteria: PATIENTS SUFFERING FROM SEVERE ANEMIA (Hb% PREGNANT PATIENTS. PATIENTS USING IUCD AND OCPs. BLEEDING SITES OTHER THAN UTERUS. PATIENTS HAVING BLEEDING DUE TO ABORTION. SYSTEMIC ILLNESS LIKE HTN,LIVER DYSFUNCTION,THYROID DYSFUNCTION,STD. PATIENTS HAVING COAGULATION DISORDERS. PATIENTS WITH UTERINE AND PELVIC PATHOLOGY LIKE FIBROID,ADENOMYOSIS,PID,ENDOMETRIAL POLYP & CA CERVIX.

Design outcomes

Primary

Measure	Time frame
RELIEF IN SIGN AND SYMPTOMS OF ASRUGDARTimepoint: 3 months.	—

Secondary

Measure	Time frame
Regularisation Of Menstrual Cycle Interval,Amount and duration of bleeding.Timepoint: 3 MONTHS	—

Countries

India

Contacts

Public ContactDr Shashi Singh

Government Ayurvedic PG College And Hospital

Shashi.aymc@gmail.com9451680560

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026